Article
Honokiol inhibits SARS-CoV-2 replication in cell culture
2022-07-27
Abstract excerpt
<h4>SUMMARY</h4> SARS-CoV-2 emerged in 2019 and since its global spread has caused the death of over 6 million people. There are currently few antiviral options for treatment of COVID-19. Repurposing of known drugs can be a fast route to obtain molecules that inhibit viral infection and/or modulate pathogenic host responses. Honokiol is a small molecule from Magnolia trees, for which several biological effects h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 03938281-e72d-5c47-8ee2-7f4805cfcff7
- DOI
- 10.1101/2022.07.26.501656
